Skip to main content
. 2004 Dec 24;4:32. doi: 10.1186/1471-2210-4-32

Table 3.

The influence of Pro and Raz on primary and metastatic tumor of LLC: PTI (%) – Primary tumor inhibition. MFCPM – metastatic foci count per mouse. Route: ip × 7 every 2 days. Experiment term was 20 days, * P < 0.001(treatment vs vehicle control). The numbers of mice were 30 for both control group and each treatment group. 100 % survival was observed in each group.

Compounds Dosage mg/kg/d Body weigh (g) PTI(%) MFCPM
Control --- 22.8/21.4 -- 30.9 ± 7.3
Razoxane 20 22.7/21.5 40.3 1.2 ± 0.5*
Probimane 30 23.3/22.5 42.0 1.5 ± 0.5*
Probimane 60 23.3/20.3 48.0 1.0 ± 0.2*